STAT3 and plasma cell myeloma: Similarly, our previous study observed that the pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC functions through the up-regulation of HSP90 and down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs [15].